A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma

• Status: RECRUITING
• Trial end date: 2027-12-01

Summary

To evaluate the efficacy and safety of TQB3702 tablets combined with immunochemotherapy for the treatment of B-cell lymphoma

• Phase: PHASE2

Details

• Lead Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.